Showing results (111-120 of 137) with videos related to

Sort By:
Pageof 14
The New England Journal of Medicine|May 19, 2016
Prospective Study of Acute HIV-1 Infection in Adults in East Africa and ThailandMerlin L Robb, Leigh A Eller, Hannah Kibuuka, et al.
Plos Pathogens|February 7, 2020
Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and ThailandMorgane Rolland, Sodsai Tovanabutra, Bethany Dearlove, et al.
The Journal of Clinical Investigation|September 21, 2023
Initial productive and latent HIV infections originate in vivo by infection of resting T cellsStephen W Wietgrefe, Jodi Anderson, Lijie Duan, et al.
Viruses|July 7, 2019
Combining Viral Genetics and Statistical Modeling to Improve HIV-1 Time-of-infection Estimation towards Enhanced Vaccine Efficacy AssessmentRaabya Rossenkhan, Morgane Rolland, Jan P L Labuschagne, et al.
Cell|November 19, 2013
Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeysDan H Barouch, Kathryn E Stephenson, Erica N Borducchi, et al.
Plos Pathogens|September 4, 2020
Adjuvanted HIV-1 vaccine promotes antibody-dependent phagocytic responses and protects against heterologous SHIV challengeKier Om, Dominic Paquin-Proulx, Maria Montero, et al.
Cells|August 25, 2019
Deep Sequencing Reveals Central Nervous System Compartmentalization in Multiple Transmitted/Founder Virus Acute HIV-1 InfectionSodsai Tovanabutra, Rujipas Sirijatuphat, Phuc T Pham, et al.
Cell Host & Microbe|March 4, 2021
B cell engagement with HIV-1 founder virus envelope predicts development of broadly neutralizing antibodiesSamantha M Townsley, Gina C Donofrio, Ningbo Jian, et al.
Nature Medicine|April 3, 2020
Safety and immunogenicity of Ad26 and MVA vaccines in acutely treated HIV and effect on viral rebound after antiretroviral therapy interruptionDonn J Colby, Michal Sarnecki, Dan H Barouch, et al.
The Journal of Clinical Investigation|November 11, 2021
Anti-HIV antibody development up to 1 year after antiretroviral therapy initiation in acute HIV infectionJulie L Mitchell, Justin Pollara, Kenneth Dietze, et al.
Pageof 14